Featured post

Holdings in Company

 

The attached TR1 notification relates to the shareholding in Source BioScience held by Artemis Investment Management LLP, which now stands at 35,003,000 shares, representing 11.16% of the Company’s ordinary share capital.

 

Latest News

Appointment to the Board

4 Sep 2014

Source BioScience plc announces that Tim Metcalfe will join the Board as Group Finance Director with immediate effect.

Read more »

Source BioScience launches intelligent GenomeCUBE search engine

1 Sep 2014

Search and buying tool offers instant, simple access to millions of clone, antibody and protein products

Read more »

Half Year Report 2014

20 Aug 2014

Source BioScience today announces its Half Year Report for the six months ended 30 June 2014.

Read more »

Appointment to the Board

3 Jul 2014

Source BioScience plc (LSE: SBS) the international laboratory services and products business, announces that Pam Liversidge, OBE will join the Board as a Non-Executive Director with immediate effect.

Read more »

Total Voting Rights

30 Jun 2014

In accordance with the FCA's Disclosure and Transparency Rules, Source BioScience plc confirms that as at 30 June 2014 the Company has 313,573,965 ordinary shares of 2 pence each in issue.

Read more »

Additional Listing on Exercise of Share Options

23 Jun 2014

Source BioScience plc announces that it has issued 125,000 new ordinary shares of 2 pence each in the Company following the exercise of options under the Company's 1999 Unapproved Share Options scheme.

Read more »